文献速递其他结缔组织病

干扰素特征可区分炎症性与免疫异常性肌病

Distinct interferon signatures stratify inflammatory and dysimmune myopathies.
PubMed 文献 · RMD Open · 2019-02-26

研究分析了39例特发性炎症性肌病(IBM、DM、NAM、ASM各亚型)及10例对照的肌肉活检中IFNα/β和IFNγ诱导基因表达。结果显示DM以I型IFNα/β特征为主,IBM和ASM以II型IFNγ特征为主,NAM无I型或II型IFN特征;肌纤维MHC-2表达是II型IFN特征的可靠生物标志物。

要点

  • DM以I型IFNα/β特征为主,IBM和ASM以II型IFNγ特征为主,NAM无IFN特征。
  • 肌纤维MHC-2表达可作为II型IFN特征的可靠生物标志物。
  • ASM和IBM中MHC-2阳性肌纤维邻近产生高水平IFNγ的CD8+ T细胞。

核心结论

  • 不同IFN特征有助于更清晰地区分特发性炎症性肌病亚型,肌纤维MHC-2表达是II型IFN特征的可靠生物标志物。

研究设计与样本

  • 纳入39例特发性炎症性肌病患者(IBM n=9、DM n=10、NAM n=10、ASM n=10)和10例对照,对肌肉活检样本定量检测IFNγ、ISG15(IFNα/β诱导基因)及六个IFNγ诱导基因(GBP2、HLA-DOB、HLA-DPB、CIITA、HLA-DRB、HLA-DMB)的表达水平。

主要发现

  • DM通常与强烈的I型IFNα/β特征相关,IBM和ASM与显著的II型IFNγ特征相关,NAM既无I型也无II型IFN特征。
  • ASM和IBM的免疫荧光研究显示肌纤维表达MHC-2和CIITA,证实IFNγ通路被诱导。
  • ASM和IBM中MHC-2阳性肌纤维邻近产生高水平IFNγ的CD8+ T细胞。

临床怎么用

  • 肌肉活检中IFN特征和肌纤维MHC-2表达有助于区分特发性炎症性肌病亚型。
  • II型IFNγ特征(如IBM和ASM)可考虑针对IFNγ通路的治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The role of interferons (IFN) in the pathophysiology of primary inflammatory and dysimmune myopathies (IDM) is increasingly investigated, notably because specific neutralisation approaches may constitute promising therapeutic tracks. In present work we analysed the muscular expression of specific IFNα/β and IFNγ-stimulated genes in patients with various types of IDM. METHODS: 39 patients with IDM with inclusion body myositis (IBM, n=9), dermatomyositis (DM, n=10), necrotising autoimmune myopathies (NAM, n=10) and antisynthetase myositis (ASM, n=10), and 10 controls were included. Quantification of expression levels of IFNγ, ISG15, an IFNα/β-inducible gene and of six IFNγ-inducible genes (GBP2, HLA-DOB, HLA-DPB, CIITA, HLA-DRB and HLA-DMB) was performed on muscle biopsy samples. RESULTS: DM usually associated with strong type I IFNα/β signature, IBM and ASM with prominent type II IFNγ signature and NAM with neither type I nor type II IFN signature. Immunofluorescence study in ASM and IBM showed myofibre expression of major histocompatibility class 2 (MHC-2) and CIITA, confirming the induction of the IFNγ pathway. Furthermore, MHC-2-positive myofibres were observed in close proximity to CD8+ T cells which produce high levels of IFNγ. CONCLUSION: Distinct IFN signatures allow a more distinct segregation of IDMs and myofibre MHC-2 expression is a reliable biomarker of type II IFN signature.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Rigolet M, Hou C, Baba Amer Y, et al. Distinct interferon signatures stratify inflammatory and dysimmune myopathies. RMD Open. 2019. PMID: 30886734. doi:10.1136/rmdopen-2018-000811

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。